Researchers at the Texas Health Center for Diagnostics and Surgery in Plano studied 504 patients who underwent procedures involving the device.
Five findings:
1. There were no secondary operations for device failure.
2. Twenty-eight patients, or 5.5 percent, required follow-up surgeries.
3. Twenty of the secondary operations were related to adjacent segment degeneration.
4. Three of the reoperations involved ACDF, and two were spinal cord stimulator implantations.
5. There was one secondary surgery for total disc replacement repositioning, one for wound infection and one for haematoma drainage.
More articles on spine devices:
What 7 device company CEOs were paid in 2018 – Stryker, NuVasive & more
10 key updates on 3D-printed spine, orthopedic devices
RTI Surgical enrolls 1st patient in 3D-printed implant study – 3 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
